[go: up one dir, main page]

FI934411L - Kinolonkarboxylsyror - Google Patents

Kinolonkarboxylsyror Download PDF

Info

Publication number
FI934411L
FI934411L FI934411A FI934411A FI934411L FI 934411 L FI934411 L FI 934411L FI 934411 A FI934411 A FI 934411A FI 934411 A FI934411 A FI 934411A FI 934411 L FI934411 L FI 934411L
Authority
FI
Finland
Prior art keywords
carboxylic acid
quinolone carboxylic
quinolone
acid
carboxylic
Prior art date
Application number
FI934411A
Other languages
English (en)
Other versions
FI934411A0 (fi
Inventor
Uwe Petersen
Wilfried Schroeck
Dieter Haebisch
Andreas Krebs
Thomas Schenke
Thomas Philipps
Klaus Grohe
Rainer Endermann
Klaus-Dieter Bremm
Karl-Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI934411A0 publication Critical patent/FI934411A0/fi
Publication of FI934411L publication Critical patent/FI934411L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI934411A 1992-10-09 1993-10-07 Kinolonkarboxylsyror FI934411L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4234078A DE4234078A1 (de) 1992-10-09 1992-10-09 Chinoloncarbonsäuren

Publications (2)

Publication Number Publication Date
FI934411A0 FI934411A0 (fi) 1993-10-07
FI934411L true FI934411L (fi) 1994-04-10

Family

ID=6470084

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934411A FI934411L (fi) 1992-10-09 1993-10-07 Kinolonkarboxylsyror

Country Status (19)

Country Link
US (1) US5480879A (fi)
EP (1) EP0591808A1 (fi)
JP (1) JPH0820587A (fi)
KR (1) KR940009193A (fi)
CN (1) CN1090285A (fi)
AU (1) AU666772B2 (fi)
CA (1) CA2107812A1 (fi)
CZ (1) CZ9302001A3 (fi)
DE (1) DE4234078A1 (fi)
FI (1) FI934411L (fi)
HU (1) HUT66376A (fi)
IL (1) IL107188A0 (fi)
MX (1) MX9306023A (fi)
NO (1) NO933393L (fi)
NZ (1) NZ248871A (fi)
PL (1) PL300628A1 (fi)
SK (1) SK109293A3 (fi)
TW (1) TW288018B (fi)
ZA (1) ZA937474B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7706394A (en) * 1994-02-25 1995-09-11 Arrieta Munguia, Judith Marcia Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
ATE253070T1 (de) * 1995-02-17 2003-11-15 Daiichi Suntory Pharma Co Ltd Penem-derivate und sie enthaltende anti- mikrobische mittel
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
WO1999014214A1 (en) * 1997-09-15 1999-03-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE19927412A1 (de) * 1999-06-16 2000-12-21 Bayer Ag Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0]nonan
DE19931115A1 (de) * 1999-07-06 2001-01-11 Bayer Ag Racemisierung von R, S-Dioxo-Benzylpyrrolopiperidin
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
WO2005123066A1 (en) * 2004-06-10 2005-12-29 Fob Synthesis, Inc. Carbapenem antibacterials with gram-negative activity and processes for their preparation
CN1325494C (zh) * 2005-08-18 2007-07-11 中国药科大学 3-位取代的萘啶酮类化合物及其制备方法和在制药中的应用
SMP200800058B (it) 2006-03-28 2009-09-07 Procter & Gamble Sali e polimorfi malati di un acido (3s, 5s) -7- [3-ammino-5-metilpiperidinil]-1-ciclopropil-1,4-diidro-8-metossi-4-osso-3-chinolincarbossilico
EP1999125A2 (en) 2006-03-28 2008-12-10 The Procter and Gamble Company A coupling process for preparing quinolone intermediates
US7692015B2 (en) * 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
IT1393337B1 (it) 2009-03-06 2012-04-20 Italiana Sint Spa Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
CN102459169B (zh) 2009-05-15 2014-12-31 莱德克斯制药有限公司 氧化还原药物衍生物
DK2590978T3 (en) 2010-06-18 2018-01-02 Fob Synthesis Inc CARBAPENEM ANTIBACTERIAL AGENTS WITH GRAM-NEGATIVE ACTIVITY
CN102952130B (zh) * 2011-08-24 2016-03-23 重庆华邦胜凯制药有限公司 手性合成(s,s)-2,8-二氮杂双环壬烷的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
JPH03188080A (ja) * 1989-12-15 1991-08-16 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
EP0492277A3 (en) * 1990-12-20 1992-10-14 F. Hoffmann-La Roche Ag Cephalosporin derivatives

Also Published As

Publication number Publication date
NZ248871A (en) 1995-12-21
IL107188A0 (en) 1994-01-25
TW288018B (fi) 1996-10-11
CN1090285A (zh) 1994-08-03
HUT66376A (en) 1994-11-28
EP0591808A1 (de) 1994-04-13
FI934411A0 (fi) 1993-10-07
US5480879A (en) 1996-01-02
SK109293A3 (en) 1994-09-07
AU4864493A (en) 1994-04-21
CZ9302001A3 (en) 1994-04-13
JPH0820587A (ja) 1996-01-23
ZA937474B (en) 1994-04-26
DE4234078A1 (de) 1994-04-14
KR940009193A (ko) 1994-05-20
MX9306023A (es) 1994-05-31
PL300628A1 (en) 1994-05-16
AU666772B2 (en) 1996-02-22
CA2107812A1 (en) 1994-04-10
NO933393D0 (no) 1993-09-23
NO933393L (no) 1994-04-11
HU9302843D0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
FI934411L (fi) Kinolonkarboxylsyror
NO924978D0 (no) Chinolon- og naftyridon-karboksylsyrederivater
FI943948L (fi) Heterosykliset hiilihappojohdannaiset
FI934460A (fi) Karboxylsyraderivat, laekemedel innehaollande dessa foereningar samt foerfaranden foer deras framstaellning
DK0693478T3 (da) Quinolinforbindelser
FI944800A0 (fi) Indoli-2-karboksyylihappojohdannaisia
NO940039D0 (no) Chinolon- og naftyridonkarboksylsyrederivater
NO922226D0 (no) 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater
DE69430972D1 (de) Carbonsäureester enthaltendes Schmiermittel
FI922095L (fi) Substituerade karboxylsyraderivat
FI914647L (fi) Foerfarande foer framstaellning av karboxylsyraanhydrider.
FI944045L (fi) Aromaattisia karboksyylihappojohdannaisia
NO930760D0 (no) Substituerte fenyleddiksyreamider
DE69133019D1 (de) Imidazolyl-alkencarbonsäuren
NO923508D0 (no) Bicykliske karboksylsyrederivater
DE59305938D1 (de) Pyridyloxy-acrylsäureester
FI960634A0 (fi) Uusia kinolonikarboksyylihappojohdannaisia
NO930520D0 (no) Bifenyl-substituerte kinolinderivater
DK637888A (da) Carboxylsyreestere
DE59205221D1 (de) 1-Alkoxyhexatrien-2-carbonsäureester
FI940869L (fi) Menetelmä karboksyylihappoanhydridien valmistamiseksi
DK0590856T3 (da) Frigørligt bundne carboxylsyrer
FI933300L (fi) Foerfarande foer rengoering av klorvaetesyra i gasform
FI922125L (fi) Mikrobidogiskt foerfarande foer framstaellning av 5-hydroxipyrazinkarboxylsyra
BR9610139A (pt) Derivado de ácido carboxílico